From The Cutting Room Floor

  1. Would You Describe Yourself As An Entrepreneur?
    9/1/2016

    “That’s an interesting question,” replies Axel Hoos, M.D., Ph.D., and the subject of a recent feature article in Life Science Leader magazine. The SVP therapeutic area head for oncology R&D and head of immuno-oncology at GSK has been in biotech before, an experience he says he very much enjoyed. “It operates differently than Big Pharma.” But to do what he was hoping to do — create an entirely new paradigm that resulted in the field of immuno-oncology — he felt he needed an environment with enough resources that one hiccup wouldn’t throw everything off.

  2. Clarity Of Purpose = Committed To A Cure
    8/1/2016

    When Mark Alles came into pharma about 30 years ago, Celgene’s current CEO says basic life and biological sciences were going through somewhat of an evolution built upon by prior knowledge.

  3. 3 Questions For Kite Pharma’s CEO
    7/1/2016

    Since the war on cancer was first declared, nearly half of those diagnosed today will be cured. Despite this incredible progress, cancer continues to gain ground, recently becoming the number one killer in 22 U.S. states.

  4. Convince Me Why Investing In Alzheimer’s R&D Is A Good Idea
    5/1/2016

    At a recent conference I overheard a VC admit that a few years ago if a biotech startup approached their company with an idea, no matter how good the data might seems, if it involved Alzheimer’s disease, his company was not interested in backing it.

  5. What The Ebola Crisis Can Teach Us About Healthcare Cost-Reduction
    4/1/2016

    Suresh Kumar, EVP of external affairs, “Sanofi EVP Weighs In On The Politics Of Drug Pricing,” chaired an Responding to Ebola panelat Davos (i.e., the World Economic Forum’s Annual Meeting, held in Davos-Klosters, Switzerland) in 2015, he found the experience enlightening. “

  6. Lessons In Leadership From Ironwood Pharmaceuticals’ CEO Peter Hecht
    2/29/2016

    The first time I sat down for a conversation with Peter Hecht, CEO and cofounder of Ironwood Pharmaceuticals toward developing the March 2016 Life Science Leader magazine cover feature, he prefaced responding to my first question by saying, “In general, I’m not a big fan of the ‘Great Man’ theory of history.

  7. For Ironwood Pharmaceuticals — Sustainable Innovation Requires Owning It
    2/29/2016

    One of the long-term goals for Ironwood Pharmaceuticals, the subject of Life Science Leader magazine’s March 2016 cover feature, has been to create a commercial engine to connect directly with the patients it aims to serve and capture the most value from the drugs it develops.

  8. Ironwood Pharmaceuticals' Corporate Culture — Just Don’t Suck
    2/29/2016

    Peter Hecht, CEO of Ironwood Pharmaceuticals, gives some candid advice on creating culture at a small pharma company.

  9. A Valuable Leadership Lesson — Keep It Simple
    2/3/2016

    The president of Novo Nordisk USA., Jesper Høiland, has worked in dozens of countries over the years. When asked what was the most important leadership lesson he’s learned that benefitted him most in his current role, he says...

  10. Tips On Transitioning To The Role Of Expatriate
    2/3/2016

    Holding up three fingers Jesper Høiland’s, the president of Novo Nordisk, says, “The advice I give to every person considering working abroad or in another environment is that they have to address these three things.